BioRestorative Therapies BRTX
NASDAQ BRTX
$2.33 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

BioRestorative Therapies (BRTX) Short term Debt (2021)

Updated

BioRestorative Therapies' Short term Debt was $58,970 in Q4 2021, up 33.5% from the prior quarter.

Analysis

BioRestorative Therapies (BRTX) Short term Debt (2021) Analysis & Trends

From Q1 2021 onward, BioRestorative Therapies has reported Short term Debt for 4 quarters.

  • Per Business Quant data, BRTX's Short term Debt in the three quarters before Q4 2021 was $44,172 (Q3 2021), $29,411 (Q2 2021) and $14,687 (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 BioRestorative Therapies 1.03 Mn -22.90 Mn 17,964.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 58,970.00
Sep 30, 2021 44,172.00
Jun 30, 2021 29,411.00
Mar 31, 2021 14,687.00
API Access

BioRestorative Therapies Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=BRTX&period=max&api_key=YOUR_API_KEY